Drug intelligence / Profile preview

MTP Neurology

Development stage: Preclinical
Lead developer: FetTech
Administration: Surgical Implantation

Overview

MTP Neurology is an extracellular matrix (ECM)-based regenerative medicine candidate developed by FetTech for the treatment of peripheral nerve injuries and the promotion of nerve regeneration. Utilizing FetTech's proprietary Multi-Tissue Platform (MTP®), the product is naturally derived and designed to provide a biological scaffold that mimics the native extracellular environment. This scaffold provides the necessary structural and biochemical cues to facilitate cellular recruitment, support axonal regrowth, and promote the body's natural repair mechanisms. Currently in the preclinical development phase, MTP Neurology is also being explored for applications in spinal cord injury.

Brand names: MTP Neurology
Other names: MTP® NeurologyMulti-Tissue Platform Neurology

Beyond the preview

Go deeper on MTP Neurology.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MTP Neurology.

Explore the full profile